{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:44:47Z","timestamp":1788471887153,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.pharmthera.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T12:03:11Z","timestamp":1552392191000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The emerging concept of \u201cindividualized cholesterol-lowering therapy\u201d: A change in paradigm"],"prefix":"10.1016","volume":"199","author":[{"given":"Dieter","family":"L\u00fctjohann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Stellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.G.","family":"Sijbrands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Weing\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2019.03.004_bb0005","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-pick C1 like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): A randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2014.02.615","article-title":"Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials","volume":"64","author":"Boekholdt","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIRCULATIONAHA.117.029095","article-title":"Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT (improved reduction of outcomes: Vytorin efficacy international trial)","volume":"136","author":"Bohula","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-2275(20)33370-8","article-title":"Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry","volume":"40","author":"Bosner","year":"1999","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0022-2275(20)39690-5","article-title":"Assessment of percent cholesterol absorption in humans with stable isotopes","volume":"34","author":"Bosner","year":"1993","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0040","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM199010043231404","article-title":"Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of the hyperlipidemias (POSCH)","volume":"323","author":"Buchwald","year":"1990","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(84)90952-5","article-title":"Epidemiology of coronary heart disease: The Framingham study","volume":"76","author":"Castelli","year":"1984","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/met.2014.0114","article-title":"Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitus","volume":"13","author":"Ciriacks","year":"2015","journal-title":"Metabolic Syndrome and Related Disorders"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2008.01.004","article-title":"Balancing cholesterol synthesis and absorption in the gastrointestinal tract","volume":"2","author":"Cohen","year":"2008","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0065","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbalip.2016.04.012","article-title":"Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes","volume":"1861","author":"D'Aquila","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.06.007","article-title":"Regulation of cholesterol homeostasis","volume":"368","author":"van der Wulp","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01716251","article-title":"Regulation of cholesterol metabolism in man and in other species","volume":"62","author":"Dietschy","year":"1984","journal-title":"Klinische Wochenschrift"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0080","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1172\/JCI106559","article-title":"Cholesterol synthesis in the intestine of man: Regional differences and control mechanisms","volume":"50","author":"Dietschy","year":"1971","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-2275(20)35728-X","article-title":"Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans","volume":"34","author":"Dietschy","year":"1993","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0090","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/eurheartj\/ehw377","article-title":"The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial","volume":"37","author":"Eisen","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0095","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1008-1050","article-title":"A gift from nature: The birth of the statins","volume":"14","author":"Endo","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1742-1241.2009.02022.x","article-title":"Lipid-altering efficacy of ezetimibe\/simvastatin 10\/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - the IN-CROSS study","volume":"63","author":"Farnier","year":"2009","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0110","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: A Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2018.10.010","article-title":"Plasma levels of the oxyphytosterol 7alpha-hydroxycampesterol are associated with cardiovascular events","volume":"279","author":"Fuhrmann","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0120","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","article-title":"Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: Results from IMPROVE-IT (improved reduction of outcomes: Vytorin efficacy international trial)","volume":"137","author":"Giugliano","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0021-9150(01)00608-6","article-title":"Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients","volume":"160","author":"Gylling","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1194\/jlr.P800042-JLR200","article-title":"Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers","volume":"50","author":"van Himbergen","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0140","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: History of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0145","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2010090987","article-title":"Rosuvastatin in diabetic hemodialysis patients","volume":"22","author":"Holdaas","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0150","doi-asserted-by":"crossref","first-page":"31610","DOI":"10.1074\/jbc.M301177200","article-title":"Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells","volume":"278","author":"Iqbal","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0155","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1194\/jlr.M500023-JLR200","article-title":"Evidence for multiple complementary pathways for efficient cholesterol absorption in mice","volume":"46","author":"Iqbal","year":"2005","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-physiol-012110-142233","article-title":"Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport","volume":"73","author":"Jia","year":"2011","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0165","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0170","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/ATVBAHA.114.304477","article-title":"Atheroma progression in hyporesponders to statin therapy","volume":"35","author":"Kataoka","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1534\/genetics.112.143362","article-title":"Lipid droplets and peroxisomes: Key players in cellular lipid homeostasis or a matter of fat--store 'em up or burn 'em down","volume":"193","author":"Kohlwein","year":"2013","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0180","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2008.484","article-title":"Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis","volume":"74","author":"Krane","year":"2008","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0185","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2009-1952","article-title":"Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin","volume":"95","author":"Lakoski","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/83799","article-title":"Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption","volume":"27","author":"Lee","year":"2001","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"HDL cholesterol: Reappraisal of its clinical relevance","volume":"106","author":"M\u00e4rz","year":"2017","journal-title":"Clinical Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0200","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1194\/jlr.P900039-JLR200","article-title":"Alterations in cholesterol absorption\/synthesis markers characterize Framingham offspring study participants with CHD","volume":"50","author":"Matthan","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0205","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.316.7138.1127","article-title":"Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators","volume":"316","author":"Miettinen","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diacare.27.1.53","article-title":"Low synthesis and high absorption of cholesterol characterize type 1 diabetes","volume":"27","author":"Miettinen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0215","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jcin.2013.02.018","article-title":"Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: A combined analysis of virtual histology intravascular ultrasound and optical coherence tomography","volume":"6","author":"Nasu","year":"2013","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1172\/JCI106079","article-title":"Distribution and turnover of cholesterol in humans","volume":"48","author":"Nestel","year":"1969","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0225","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: The GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0230","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2215\/CJN.05170511","article-title":"Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients","volume":"7","author":"Rogacev","year":"2012","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0235","first-page":"1","article-title":"ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: From preclinical studies to phase 3 trials","volume":"27","author":"Ruscica","year":"2019","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0240","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group","volume":"333","author":"Shepherd","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0245","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jacc.2015.03.551","article-title":"Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients","volume":"65","author":"Silbernagel","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0250","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1194\/jlr.P002899","article-title":"The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality","volume":"51","author":"Silbernagel","year":"2010","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1194\/jlr.P800013-JLR200","article-title":"The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease","volume":"50","author":"Silbernagel","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2478\/rrlm-2018-0003","article-title":"Elevated urinary methylmalonic acid\/creatinine ratio and sterum sterol levels in patients with acute ischemic stroke","volume":"26","author":"Sivrikaya","year":"2018","journal-title":"Revista Romana de Medicina de Laborator"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0265","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1056\/NEJMoa1405386","article-title":"Inactivating mutations in NPC1L1 and protection from coronary heart disease","volume":"371","author":"Stitziel","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pharmthera.2004.10.011","article-title":"Sterol transporters: Targets of natural sterols and new lipid lowering drugs","volume":"105","author":"Sudhop","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0275","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-004-0165-2","article-title":"Sitosterolemia--a rare disease. Are elevated plant sterols an additional risk factor?","volume":"93","author":"Sudhop","year":"2004","journal-title":"Zeitschrift f\u00fcr Kardiologie"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0280","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.amjcard.2009.05.019","article-title":"Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease","volume":"104","author":"Teoh","year":"2009","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCGENETICS.109.907873","article-title":"Genetic regulation of serum phytosterol levels and risk of coronary artery disease","volume":"3","author":"Teupser","year":"2010","journal-title":"Circulation. Cardiovascular Genetics"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5414\/CPP43305","article-title":"Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine","volume":"43","author":"Thuluva","year":"2005","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0295","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: The multicenter randomized controlled PRECISE-IVUS trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0300","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.physiol.69.031905.160725","article-title":"Regulation of intestinal cholesterol absorption","volume":"69","author":"Wang","year":"2007","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0310","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.atherosclerosis.2010.01.003","article-title":"Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk","volume":"210","author":"Weing\u00e4rtner","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0030-1269438","article-title":"Cholesterol homeostasis and cardiovascular risk","volume":"136","author":"Weing\u00e4rtner","year":"2011","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0320","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jacc.2007.09.074","article-title":"Vascular effects of diet supplementation with plant sterols","volume":"51","author":"Weing\u00e4rtner","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0325","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJMc1500124","article-title":"Mutations in NPC1L1 and coronary heart disease","volume":"372","author":"Weing\u00e4rtner","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0330","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jsbmb.2016.05.016","article-title":"Individualized lipid-lowering therapy to further reduce residual cardiovascular risk","volume":"169","author":"Weing\u00e4rtner","year":"2017","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0335","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MCA.0b013e32832fa947","article-title":"Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis","volume":"20","author":"Weing\u00e4rtner","year":"2009","journal-title":"Coronary Artery Disease"},{"key":"10.1016\/j.pharmthera.2019.03.004_bb0340","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2018.04.036","article-title":"Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER","volume":"274","author":"Yamaguchi","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:58:04Z","timestamp":1759010284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819300439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":68,"alternative-id":["S0163725819300439"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.03.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging concept of \u201cindividualized cholesterol-lowering therapy\u201d: A change in paradigm","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}